Ceramide mediates lung fibrosis in cystic fibrosis.
Ceramide mediates lung fibrosis in cystic fibrosis.
复制标题
DOI:
10.1016/j.bbrc.2013.03.032
复制
发表时间:
2013-05-17
影响因子:
3.1
通讯作者:
Gulbins, Erich
中科院分区:
文献类型:
--
作者:
Ziobro, Regan;Henry, Brian;Edwards, Michael J.;Lentsch, Alex B.;Gulbins, Erich
Fibrosis of the lung is one of the major clinical problems of cystic fibrosis and chronic obstructive pulmonary disease. However, the molecular mechanisms leading to pulmonary fibrosis are poorly characterized and require definition. Here, we demonstrate that chronic accumulation of ceramide in the lung contributes to the development of fibrosis in aged cystic fibrosis mice. Genetic or pharmacological normalization of ceramide in cystic fibrosis mice, which was achieved by heterozygosity of acid sphingomyelinase or chronic (6.5 month long) treatment of mice with pharmacological inhibitors of acid sphingomyelinase significantly decreased the development of lung fibrosis. Moreover, our studies demonstrate that long-term treatment of cystic fibrosis mice with pharmacological inhibitors of acid sphingomyelinase or genetic heterozygosity of the enzyme also minimizes pulmonary inflammatory cytokines in cystic fibrosis mice. This data identifies ceramide as a key molecule associated with pulmonary fibrosis in cystic fibrosis mice and demonstrate for the first time that prolonged inhibition of acid sphingomyelinase is able to attenuate fibrosis and inflammation in this animal model.
登录
查看更多内容
DOI:
10.1165/ajrcmb.11.6.7946394
发表时间:
1994-12-01
影响因子:
6.4
作者:
INOUE, H;MASSION, PP;NADEL, JA
通讯作者:
NADEL, JA
DOI:
10.1165/rcmb.2009-0174oc
发表时间:
2010-06-01
影响因子:
6.4
作者:
Becker, Katrin Anne;Riethmueller, Joachim;Gulbins, Erich
通讯作者:
Gulbins, Erich
影响因子:
4.8
作者:
Bourbon, NA;Yun, J;Kester, M
通讯作者:
Kester, M
DOI:
10.1165/ajrcmb.23.2.4214
发表时间:
2000-08-01
影响因子:
6.4
作者:
Tirouvanziam, R;de Bentzmann, S;Puchelle, E
通讯作者:
Puchelle, E
DOI:
10.1152/ajplung.00408.2010
发表时间:
2011-06-01
影响因子:
4.9
作者:
Bodas, Manish;Min, Taehong;Vij, Neeraj
通讯作者:
Vij, Neeraj